KURT ASHACK: Open Payments
NPI 1073976338 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$57,584 in 95 payments from 12 companies in 2025. Trend: 2023 $39,519 · 2024 $78,828 · 2025 $57,584
Speaker / faculty: $55,300Food & beverage: $1,264Travel & lodging: $935Education: $85
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 45 | $51,041 |
| Janssen Biotech, Inc. | 8 | $5,712 |
| ABBVIE INC. | 17 | $368 |
| GENZYME CORPORATION | 15 | $251 |
| Regeneron Healthcare Solutions, Inc. | 3 | $96 |
| Galderma Laboratories, L.P. | 1 | $20 |
| UCB, Inc. | 1 | $19 |
| Organon LLC | 1 | $18 |
| KYOWA KIRIN, INC. | 1 | $16 |
| Arcutis Biotherapeutics, Inc. | 1 | $15 |
Products named: EBGLYSS, TREMFYA, DUPIXENT, RINVOQ, SKYRIZI, TALTZ, NEMLUVIO, Bimzelx.
Industry payments across MI — which companies pay providers there.
